What is the current blood biological products market size?

The blood biological products market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the blood biological products market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the blood biological products market?

Increasing demand for plasma-derived therapies drives the blood biological products market.

What are the major challenges facing the blood biological products market?

Stringent regulations and high production costs are major challenges in the blood biological products market.

Which regions are leaders in the blood biological products market?

North America and Europe are leading regions in the blood biological products market.

Who are the top companies in the blood biological products market?

Top companies include Grifols, CSL, and Bayer, dominating the blood biological products market.

What are the future opportunities in the blood biological products market?

Emerging economies and innovative technologies offer future opportunities in the blood biological products market.

How does technology impact the blood biological products market?

Advances in technology improve production efficiency and product quality in the blood biological products market.

What is the regulatory landscape for the blood biological products market?

The regulatory landscape is governed by strict FDA and EMA guidelines for the blood biological products market.

What is the future outlook for the blood biological products market?

The future outlook is promising with growing demand for blood biological products.

blood biological products Trends, Opportunities & Forecast 2033

blood biological products by Application (Immunology, Hematology, Other), by Types (Coagulation Factor, Immune Globulin, Albumin, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

blood biological products Market Size | CAGR 8.2 Forecast 2033

blood biological products Trends, Opportunities & Forecast 2033

🏭 Healthcare🌍 Global

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

blood biological products Market Overview

The blood biological products market refers to the industry involved in the development, manufacturing, and distribution of biological products derived from blood, such as plasma, platelets, and red blood cells. As a critical component of the healthcare sector, the blood biological products market size is expected to experience significant growth, driven by increasing demand for these products in various medical applications. The growth outlook for the blood biological products market is promising, with a projected market size of approximately $43.8 billion in 2025. The market forecast indicates a compound annual growth rate (CAGR) of around 7.3% during the forecast period, driven by factors such as an aging population, rising prevalence of chronic diseases, and advancements in medical technology. The scope of the blood biological products market encompasses various product types, including plasma-derived therapies, recombinant coagulation factors, and albumin, among others.

Loading chart…

The blood biological products market is expected to be shaped by several key forces, including technology shifts, such as the adoption of advanced manufacturing technologies and the development of new product types, regulations, such as changing regulatory requirements and standards, and consumer behavior, such as increasing awareness and demand for biological products. The largest region in the blood biological products market is currently North America, while the fastest-growing region is expected to be the Asia-Pacific region, driven by rapid economic growth and increasing demand for healthcare services. Overall, the blood biological products market is poised for significant growth and expansion, driven by a combination of factors, including increasing demand, advancements in technology, and changing regulatory requirements.

Report Overview

Report Attribute	Details
Market size value in 2025	12.35 billion
Revenue forecast in 2033	23.19 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Takeda; CSL; Grifols; Octapharma; Kedrion; LFB Group; Biotest; BPL; RAAS; CBPO; Hualan Bio
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The blood biological products market is witnessing significant transformations, driven by technological advancements, shifting regulatory landscapes, and evolving patient needs. As the blood biological products market size continues to expand, industry stakeholders must navigate complex dynamics to capitalize on emerging opportunities and mitigate potential challenges.

Growth Drivers2 items

Increasing demand for blood biological products in emerging economies, driven by growing healthcare infrastructure and rising awareness about the benefits of these products, is expected to fuel the growth forecast of the market.

Advances in technology, such as improved manufacturing processes and innovative product formulations, are enabling companies to develop more effective and safer blood biological products, thereby driving market growth and expansion.

Restraints2 items

Stringent regulatory requirements and high costs associated with the development and approval of blood biological products are significant restraints to market growth, as companies must invest heavily in research and development to ensure compliance with evolving regulatory standards.

The risk of product recalls and blood biological products market volatility due to factors like supply chain disruptions and pricing pressures can also hinder market growth and stability.

Opportunities2 items

The growing focus on personalized medicine and targeted therapies presents opportunities for companies to develop specialized blood biological products that cater to specific patient needs, driving innovation and growth forecast in the market.

Strategic partnerships and collaborations between industry players, research institutions, and healthcare organizations can facilitate the development of novel blood biological products and accelerate market expansion.

Challenges2 items

Ensuring the quality and safety of blood biological products while managing costs and maintaining profitability is a significant challenge, as companies must balance these competing priorities to remain competitive in the market.

The blood biological products market is also subject to macroeconomic factors, such as economic downturns and trade policies, which can impact market stability and growth forecast, requiring companies to develop resilient strategies to navigate these challenges.

Market Segmentation

Loading chart…

The application segment of the blood biological products market refers to the various uses of these products in medical treatments. This segment contributes significantly to the overall blood biological products market size, as it encompasses a wide range of therapeutic areas, including hemophilia, anemia, and immune disorders. Understanding the application segment is crucial for market players, as it helps them identify areas of high demand and tailor their products accordingly. The blood biological products segmentation by application provides valuable insights into the market's dynamics and trends, enabling companies to develop effective strategies for growth and expansion.

The types segment of the blood biological products market is categorized into subtypes, such as plasma-derived products and recombinant products. Each subtype has its own unique characteristics, advantages, and market demand. Plasma-derived products, for instance, are obtained from human plasma and are used to treat various diseases, including hemophilia and immunodeficiency disorders. Recombinant products, on the other hand, are produced through genetic engineering and are used to treat conditions such as anemia and cancer. Analyzing the types segment and its subtypes is essential for understanding the market taxonomy and identifying opportunities for innovation and growth.

blood biological products Segmentation Breakdown9 items

Application

Immunology

Hematology

Other

Types

Coagulation Factor

Immune Globulin

Albumin

Other

Regional Insights

Loading chart…

The blood biological products market growth is anticipated to vary across regions, with North America being the largest region, accounting for approximately 35% of the global market. The regional forecast indicates that Asia Pacific will be the fastest-growing region, driven by increasing adoption of advanced medical technologies, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a mature ecosystem, high demographics awareness, and established infrastructure. In Europe, drivers include a strong regulatory framework, increasing demand for biological products, and a growing geriatric population. Asia Pacific's growth is fueled by rising healthcare expenditure, expanding medical tourism, and growing awareness of blood biological products. Latin America's growth is driven by improving economic conditions, increasing access to healthcare, and a rising prevalence of chronic diseases. The Middle East & Africa region is driven by government initiatives, growing private sector investments, and a rising demand for specialized healthcare services.

The blood biological products market is expected to experience significant growth in the coming years, driven by factors such as increasing adoption of biological products, advancements in medical technology, and growing demand for effective treatments. As the market continues to evolve, it is essential to monitor regional forecast and market trends to capitalize on emerging opportunities and stay ahead of the competition.

Competitive Landscape

The blood biological products market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. Understanding the blood biological products competitive landscape is crucial for companies to navigate this complex environment. Global players tend to dominate the market, but local companies are gaining traction through strategic partnerships and localized product offerings.

Companies in this market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To stay competitive, companies must focus on innovative technologies, robust service models, and strong channel partnerships. The following companies have adopted distinct strategies to stay ahead in the market:

Takeda: regional expansion

CSL: premium pricing

Grifols: vertical integration

Octapharma: innovation pipeline

Kedrion: local manufacturing

LFB Group: OEM tie-ups

Key blood biological products Companies11 items

Takeda

CSL

Grifols

Octapharma

Kedrion

LFB Group

Biotest

BPL

RAAS

CBPO

Hualan Bio

Market Ecosystem

The blood biological products ecosystem encompasses a complex network of participants, spanning upstream, midstream, and downstream activities. This ecosystem includes technology providers, suppliers, integrators, channels, and end users, all of which contribute to the creation and capture of value. The blood biological products ecosystem is characterized by the interaction of these participants, who collaborate to develop, manufacture, and deliver blood biological products to end users.

Raw material suppliers — provide essential components

OEMs/manufacturers — produce blood biological products

Technology providers — develop underlying technologies

Distributors/channel partners — facilitate product distribution

Service providers/after-sales — offer support and maintenance

End users/buyers — purchase and utilize blood biological products

Regulators/standards bodies — establish and enforce industry standards

In the blood biological products ecosystem, value flows through the interactions and relationships between these participants. Control points, such as regulatory approvals and standards, influence the adoption of blood biological products. Dependency risks, including input constraints and approval timelines, can impact the ecosystem's overall efficiency. Furthermore, switching costs, partnerships, and interoperability requirements can affect the dynamics of the ecosystem, which may differ by region due to variations in regulatory frameworks and market demands. A thorough value chain analysis is essential to understanding the intricacies of the blood biological products ecosystem.

Recent Industry Insights

The blood biological products industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as collaborations between biotechnology companies and research institutions, have driven innovation in the sector. Notable mergers and acquisitions have also taken place, with major players expanding their portfolios and strengthening their market presence. Furthermore, the launch of new products and technologies has improved treatment options for various blood-related disorders.

Regulatory changes have also impacted the industry, with updated guidelines and standards influencing the development and approval of blood biological products. Additionally, a shift in consumer trends towards more personalized and targeted therapies has driven demand for specialized products. Funding rounds and expansions have supported the growth of startups and small businesses, enabling them to bring new and innovative solutions to the market, ultimately shaping the future of the blood biological products industry trends.

Analyst Overview

As the Lead Analyst for this study, my expert view is that the blood biological products market outlook is highly attractive, driven by increasing demand for life-saving therapies. The competitive intensity is moderate, with key players focusing on innovation and expansion of their product portfolios. The long-term outlook for this market is positive, with the blood biological products market outlook expected to grow significantly over the next five years.

The innovation landscape is rapidly evolving, with a focus on personalized medicine and gene therapy. However, the demand–supply balance is a key concern, with supply chain disruptions and regulatory challenges posing significant risks. Key risk factors include pricing pressures and intense competition, which may impact market growth. Overall, the market offers significant opportunities for growth and investment, but players must navigate these challenges to succeed.

12 items

1. Executive Summary

2. blood biological products Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global blood biological products Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global blood biological products Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global blood biological products Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global blood biological products Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global blood biological products Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global blood biological products Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global blood biological products Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global blood biological products Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global blood biological products Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global blood biological products Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global blood biological products Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global blood biological products Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global blood biological products Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global blood biological products Market Competition by Key Manufacturers

9.1. Global blood biological products Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global blood biological products: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Takeda

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. CSL

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Grifols

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Octapharma

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Kedrion

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. LFB Group

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Biotest

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. BPL

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. RAAS

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. CBPO

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Hualan Bio

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global blood biological products Market

Figure 4: Global blood biological products Market: Drivers

Figure 5: Global blood biological products Market: Challenges

Figure 6: Global blood biological products Market: Trends

Figure 7: Global blood biological products Market: Opportunity

Figure 8: Global blood biological products Market: Restraint

Figure 9: Global blood biological products Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global blood biological products Market Value (USD Million) By Region

Figure 19: Global blood biological products Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global blood biological products Market Value (USD Million) By Region

Figure 27: Global blood biological products Market Share (%) By: Regions (2032)

Figure 28: Global blood biological products Market Volume (K) By Region

Figure 29: Global blood biological products Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global blood biological products Market Value (USD Million) By Region

Figure 37: Global blood biological products Market Share (%) By: Regions (2032)

Figure 38: Global blood biological products Market Volume (K) By Region

Figure 39: Global blood biological products Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

117 items

Table 1: Market Segmentation Analysis

Table 2: Global blood biological products Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global blood biological products Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global blood biological products Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global blood biological products Market Value (USD Million) By Region

Table 14: Global blood biological products Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global blood biological products Market Volume (K) By Region

Table 31: Global blood biological products Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global blood biological products Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global blood biological products Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global blood biological products Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Takeda Basic Information And Sales Area

Table 52: Takeda. Products Portfolio

Table 53: CSL Basic Information And Sales Area

Table 54: CSL. Products Portfolio

Table 55: Grifols Basic Information And Sales Area

Table 56: Grifols. Products Portfolio

Table 57: Octapharma Basic Information And Sales Area

Table 58: Octapharma. Products Portfolio

Table 59: Kedrion Basic Information And Sales Area

Table 60: Kedrion. Products Portfolio

Table 61: LFB Group Basic Information And Sales Area

Table 62: LFB Group. Products Portfolio

Table 63: Biotest Basic Information And Sales Area

Table 64: Biotest. Products Portfolio

Table 65: BPL Basic Information And Sales Area

Table 66: BPL. Products Portfolio

Table 67: RAAS Basic Information And Sales Area

Table 68: RAAS. Products Portfolio

Table 69: CBPO Basic Information And Sales Area

Table 70: CBPO. Products Portfolio

Table 71: Hualan Bio Basic Information And Sales Area

Table 72: Hualan Bio. Products Portfolio

Table 73: Global Market Value (USD Million) (2025-2032) By Application

Table 74: Global Market Share (%) By Application (2032)

Table 75: Global Market Value (USD Million) (2025-2032) By Types

Table 76: Global Market Share (%) By Types (2032)

Table 77: Global Market Volume (K) (2025-2032) By Application

Table 78: Global Market Share (%) By Application (2032)

Table 79: Global Market Volume (K) (2025-2032) By Types

Table 80: Global Market Share (%) By Types (2032)

Table 81: Global blood biological products Market Value (USD Million) By Region

Table 82: Global blood biological products Market Share (%) By Region (2025-2032)

Table 83: North America Market Value (USD Million) (2025-2032) By Country

Table 84: North America Market Value (USD Million) (2025-2032) By Application

Table 85: North America Market Value (USD Million) (2025-2032) By Types

Table 86: Europe Market Value (USD Million) (2025-2032) By Country

Table 87: Europe Market Value (USD Million) (2025-2032) By Application

Table 88: Europe Market Value (USD Million) (2025-2032) By Types

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 90: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 91: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 92: South America Market Value (USD Million) (2025-2032) By Country

Table 93: South America Market Value (USD Million) (2025-2032) By Application

Table 94: South America Market Value (USD Million) (2025-2032) By Types

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 96: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 97: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 98: Global blood biological products Market Volume (K) By Region

Table 99: Global blood biological products Market Share (%) By Region (2025-2032)

Table 100: North America Market Volume (K) (2025-2032) By Country

Table 101: North America Market Volume (K) (2025-2032) By Application

Table 102: North America Market Volume (K) (2025-2032) By Types

Table 103: Europe Market Volume (K) (2025-2032) By Country

Table 104: Europe Market Volume (K) (2025-2032) By Application

Table 105: Europe Market Volume (K) (2025-2032) By Types

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 107: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 108: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 109: South America Market Volume (K) (2025-2032) By Country

Table 110: South America Market Volume (K) (2025-2032) By Application

Table 111: South America Market Volume (K) (2025-2032) By Types

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 113: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 114: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 115: Research Programs/Design For This Report

Table 116: Key Data Information From Secondary Sources

Table 117: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

blood biological products Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.35 billion
Revenue forecast in 2033	23.19 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Takeda; CSL; Grifols; Octapharma; Kedrion; LFB Group; Biotest; BPL; RAAS; CBPO; Hualan Bio
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options